Chris Degnan, Chief Financial Officer at Verrica Pharmaceuticals Inc. (VRCA), bought 3,000 shares at $15.00 ($45K) on 2018-06-19, disclosed to the SEC on 2018-08-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| GRTX | BUY | 2023-03-14 | $20K | — | Filing → |